当前位置: 首页 > 期刊 > 《医学信息》 > 2023年第7期
编号:2333041
我国社区非瓣膜性心房颤动患者抗凝治疗的管理现状
http://www.100md.com 2023年12月29日 医学信息 2023年第7期
     摘要:心房颤动是最常见的心律失常之一,卒中是其最严重的并发症。抗凝治疗可极大程度上减少房颤相关脑卒中事件的发生。对于房颤患者,分级诊疗制度的推行使得基层机构已逐渐成为其就医的首要选择。本文主要综述我国社区非瓣膜性房颤患者抗凝治疗的现状,旨在加强临床对房颤患者抗凝治疗社区管理的重视。

    关键词:心房颤动;社区管理;抗凝治疗

    中图分类号:R541" " " " " " " " " " " " " " " " " "文献标识码:A" " " " " " " " " " " " " " " " "DOI:10.3969/j.issn.1006-1959.2023.07.037

    文章编号:1006-1959(2023)07-0180-04

    Management Status of Anticoagulant Therapy for Patients with Nonvalvular Atrial Fibrillation

    in Community of China

    LI Hao-yang1,2,ZHANG Bei1,WU Jiang3,YAN Qin-qin4

    (1.Department of Neurology,the First Affiliated Hospital of Xi'an Medical University,Xi 'an 710000,Shaanxi,China;

    2.Graduate School of Xi'an Medical University,Xi'an 710000,Shaanxi,China;

    3.Xi'an Hansenzhai Community Health Service Center,Xi'an 710000,Shaanxi,China;

    4.Institute of General Practice,Xi'an Medical University,Xi'an 710000,Shaanxi,China)

    Abstract:Atrial fibrillation is one of the most common arrhythmias, and stroke is the most serious complication. Anticoagulant therapy can greatly reduce the incidence of atrial fibrillation-related stroke events. For patients with atrial fibrillation ......

您现在查看是摘要页,全文长 15997 字符